Quantbot Technologies LP Alector, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $11,310 - $25,170	3,000 New	3,000 $23,000
Q4 2022 Feb 13, 2023	BUY	$6.88 - $9.55 $105,952 - $147,070	15,400 Added 905.88%	17,100 $157,000
Q3 2022 Nov 07, 2022	SELL	$8.19 - $13.2 $74,217 - $119,618	-9,062 Reduced 84.2%	1,700 $16,000
Q2 2022 Aug 09, 2022	BUY	$7.65 - $14.24 $68,559 - $127,618	8,962 Added 497.89%	10,762 $109,000
Q1 2022 May 16, 2022	BUY	$13.02 - $20.78 $23,436 - $37,404	1,800 New	1,800 $25,000

165

58.1M

57K

14.9K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $386M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.